HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Santosh Kumar Goru Selected Research

esculetin

11/2017Esculetin ameliorates vascular perturbation by intervening in the occupancy of H2BK120Ub at At1, At2, Tgfβ1 and Mcp1 promoter gene in thoracic aorta of IR and T2D rats.
9/2017Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.
8/2017Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway.
10/2015Insulin sensitizing and cardioprotective effects of Esculetin and Telmisartan combination by attenuating Ang II mediated vascular reactivity and cardiac fibrosis.
5/2015Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Santosh Kumar Goru Research Topics

Disease

6Fibrosis (Cirrhosis)
01/2022 - 10/2015
5Insulin Resistance
11/2017 - 10/2015
3Diabetic Nephropathies (Diabetic Nephropathy)
06/2018 - 12/2016
3Inflammation (Inflammations)
08/2017 - 04/2016
2Diabetic Cardiomyopathies
11/2017 - 09/2017
2Atherosclerosis
06/2017 - 04/2016
2Obesity
06/2017 - 04/2016
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2016 - 05/2015
1Cicatrix (Scar)
01/2022
1Chronic Disease (Chronic Diseases)
01/2022
1Disease Progression
01/2022
1Cardiomyopathies (Cardiomyopathy)
09/2017
1Liver Cirrhosis (Hepatic Cirrhosis)
08/2017
1Non-alcoholic Fatty Liver Disease
08/2017
1Neoplasms (Cancer)
06/2017
1Asthma (Bronchial Asthma)
04/2016
1Renal Insufficiency (Renal Failure)
11/2015
1Type 2 Diabetes Mellitus (MODY)
10/2015
1Hyperglycemia
05/2015
1Hyperinsulinism (Hyperinsulinemia)
05/2015

Drug/Important Bio-Agent (IBA)

5esculetinIBA
11/2017 - 05/2015
3Histones (Histone)IBA
06/2018 - 11/2016
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 12/2016
2Proteins (Proteins, Gene)FDA Link
06/2018 - 08/2017
2Fibronectins (Fibronectin)IBA
09/2017 - 08/2017
2Telmisartan (Micardis)FDA Link
09/2017 - 10/2015
2Angiotensin IIIBA
04/2016 - 11/2015
1EnzymesIBA
06/2018
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2018
1FatsIBA
08/2017
1CollagenIBA
08/2017
1AntioxidantsIBA
08/2017
1Proteasome Endopeptidase Complex (Proteasome)IBA
06/2017
1UbiquitinIBA
06/2017
1ChromatinIBA
12/2016
1Monocyte Chemoattractant ProteinsIBA
12/2016
1Lysine (L-Lysine)FDA Link
12/2016
1Angiotensin Receptors (Angiotensin II Receptor)IBA
12/2016
1Pharmaceutical PreparationsIBA
04/2016
1Ligases (Synthetase)IBA
04/2016
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
11/2015
1Angiotensin-Converting Enzyme 2IBA
11/2015
1Insulin (Novolin)FDA Link
10/2015
1Streptozocin (Streptozotocin)FDA Link
05/2015
1Acetylcholine (Acetylcholine Chloride)FDA Link
05/2015

Therapy/Procedure

2Therapeutics
01/2022 - 08/2017